Bifikafusp alfa–onfekafusp alfa for neoadjuvant treatment of 3B or 3C resectable melanoma [ID6384]

  • Awaiting development
  • GID-TA11458
  • Expected publication date: TBC

6380-Daromun-for-Melanoma-V1.0-SEP2023-NON-CONF.pdf (nihr.ac.uk)